sulfinpyrazone has been researched along with Hematologic Diseases in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Hematologic Diseases: Disorders of the blood and blood forming tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, S | 1 |
| de Carvalho, RI | 1 |
| Givisiez, AN | 1 |
| Cardoso, JR | 1 |
2 other studies available for sulfinpyrazone and Hematologic Diseases
| Article | Year |
|---|---|
Hazards of sulphinpyrazone.
Topics: Drug Synergism; Hematologic Diseases; Humans; Hypoglycemic Agents; Sulfinpyrazone; Uricosuric Agents | 1979 |
[Effect of sulfinpyrazone(Anturan) on the uric acid metabolism in malignant blood diseases].
Topics: Adult; Female; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Male; Sulfinpyrazone; Uric A | 1969 |